The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes

Inclusion Criteria: * Diagnosed with type 2 diabetes * HbA1c: 6.5-9.0% * Capable of understanding oral- and written information * Caucasian Exclusion Criteria: * Estimated glomerular filtration rate (eGFR) \< 60 mL/hour/1.73 m2 * Currently receiving insulin treatment * Coronary artery bypass grafting, percutaneous coronary intervention, acute coronary syndrome, stroke, lung embolism, deep vein thrombosis, or transitory cerebral ischemia within 6 months * Genital infection within 14 days * Plasma alanine aminotransferase ≥3 times upper normal limit * Treatment with sodium glucose cotransporter (SGLT) -2 inhibitor within 2 months * Hyperglycaemic symptoms * Psychiatric disorder * Intolerance to empagliflozin or other agents relevant to study * Non-compliant